The cardiovascular market research reports by iData cover Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management and the Electrophysiology market. The fastest growing segments within interventional cardiology are expected to be driven by new technologies, such as CTO crossers, FFR guidewires and OCT catheters. The vascular access market will grow due to a combination of increasing patient population and the shift towards technologically advanced devices that will continue to gain market share at the expense of older, less expensive devices. iData’s cardiovascular device market reports also include cardiac surgery, cardiac rhythm management, and other cardiovascular devices and procedures. Check out our different cardiovascular device market reports below.
In 2019, the global syringe and needle market size was valued at $6.8 billion, with the majority of the market size occupied by the needles segment. The global market size is set to expand partially due to the COVID19 pandemic and exceed $7.5 billion in 2026. In North America and Europe, the majority of the
By 2020, the global pacemaker market size was valued at $2.26 billion, with over 450,000 pacemaker procedures performed annually. The market size is expected to further increase over the forecast period and reach $2.6 billion in 2025. Throughout this medical market research, we analyzed global pacemaker companies across more than 70 countries and used our comprehensive methodology
In 2020, the U.S. Transcatheter Aortic Valve Replacement (TAVR) market size was valued at almost $2.4 billion, with over 75,000 TAVR procedures performed annually. In spite of COVID19, the market size is expected to increase at a cumulative growth rate of 8.7% to reach almost $5 billion in 2026. Throughout this medical market research, we
By 2020, the global central venous catheter (CVC) market size was valued at approximately $763 million, with over 27 million CVC insertion procedures performed every year. The global market size is expected to reach $860 million in 2026. The overwhelming majority of the global central venous catheter market share was controlled by Teleflex, Becton Dickinson,